Spots Global Cancer Trial Database for bladder carcinoma

Every month we try and update this database with for bladder carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy	NCT01245660	Bladder Carcino... Infiltrative Bl... Cystectomy	LAPATINIB	18 Years -	University Hospital, Bordeaux
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers	NCT04459273	Bladder Carcino... Cervical Carcin... Cholangiocarcin... Hematopoietic a... Hepatocellular ... Malignant Adren... Malignant Brain... Malignant Pleur... Malignant Skin ... Malignant Solid... Malignant Testi... Malignant Thymu... Neuroendocrine ... Thyroid Gland C... Urothelial Carc... Cancer of Unkno...	Computed Tomogr... Gallium Ga 68 F... Positron Emissi... 18F-FDG	18 Years -	Jonsson Comprehensive Cancer Center
Evaluating Sexual Function in Women Undergoing a Radical Cystectomy for Bladder Cancer	NCT05399004	Bladder Carcino...	Survey Administ...	18 Years -	Mayo Clinic
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy	NCT02145390	Bladder Cancer Bladder Carcino... Transition Cell... Muscle Invasive...	Transurethral R... Intensity Modul... Expanded Prosta... International P...	18 Years -	University of Miami
Cone Beam CT Scanning in Lung and Bladder Cancer.	NCT00469066	Lung Neoplasm Small Cell Carc... Bladder Carcino...		18 Years -	AHS Cancer Control Alberta
First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma	NCT01215136	Transitional Ce... Bladder Carcino... Urothelial Carc...	Everolimus Everolimus Paclitaxel	18 Years -	Hoosier Cancer Research Network
Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy	NCT04502095	Bladder Carcino... Refractory Blad... Urinary Tract I...	Clindamycin Diary Ertapenem Levofloxacin Nitrofurantoin Trimethoprim-Su...	18 Years -	Roswell Park Cancer Institute
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy	NCT02145390	Bladder Cancer Bladder Carcino... Transition Cell... Muscle Invasive...	Transurethral R... Intensity Modul... Expanded Prosta... International P...	18 Years -	University of Miami
Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy	NCT04502095	Bladder Carcino... Refractory Blad... Urinary Tract I...	Clindamycin Diary Ertapenem Levofloxacin Nitrofurantoin Trimethoprim-Su...	18 Years -	Roswell Park Cancer Institute
TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer	NCT03125226	Bladder Carcino...	Polyethylene Gl...	18 Years -	University of Washington
EffectiveNess of a Multimodal preHAbilitation Program in patieNts With Bladder canCEr Undergoing Cystectomy	NCT05480735	Bladder Carcino...	Prehabilitation	18 Years -	The Netherlands Cancer Institute
Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery	NCT02169284	Bladder Carcino... Recurrent Bladd...	Erlotinib Hydro... Laboratory Biom... Pharmacological... Placebo Quality-of-Life... Therapeutic Con...	18 Years -	National Cancer Institute (NCI)
Vaccine Response With NT-I7	NCT04054752	Breast Carcinom... Colorectal Aden... Bladder Carcino...	Recombinant hum... Vaccine sequenc... Vaccine sequenc...	60 Years -	National Institutes of Health Clinical Center (CC)
A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours	NCT05363605	Advanced Solid ... Head and Neck S... Bladder Carcino... Susceptible FGF... FGFR3 FGFR3 Overexpre... FGFR3 Receptor FGFR3 Protein O... Ovarian Cancer Colorectal Canc... Breast Cancer Liver Cancer Lung Cancer Gastric Cancer	[225Ac]-FPI-196... [111In]-FPI-196... vofatamab	18 Years -	Fusion Pharmaceuticals Inc.
Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer	NCT02438852	Bladder Carcino... Post-operative ...	Placebo Questionnaire A... Ropivacaine Hyd...	18 Years -	University of Southern California
First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma	NCT01215136	Transitional Ce... Bladder Carcino... Urothelial Carc...	Everolimus Everolimus Paclitaxel	18 Years -	Hoosier Cancer Research Network
Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01)	NCT04922047	Urinary Bladder... Urologic Neopla... Urogenital Neop... Antineoplastic ... Urinary Bladder... Tislelizumab An...	tislelizumab an...	18 Years - 75 Years	RenJi Hospital
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics	NCT05819827	Bladder Cancer Prostate Cancer Testicular Canc... Bladder Carcino... Genitourinary S... Malignant Testi... Melanoma Prostate Carcin... Sarcoma	Blood and Tissu...	20 Years -	Mayo Clinic
First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder Carcinoma	NCT03324282	Bladder Carcino...	Avelumab GC	18 Years -	University Hospital, Bordeaux
Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery	NCT03757949	Bladder Carcino...	Laboratory Biom... Nutritional Int... Placebo Adminis... Quality-of-Life... Questionnaire A...	18 Years -	SWOG Cancer Research Network
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)	NCT02465060	Advanced Lympho... Advanced Malign... Bladder Carcino... Breast Carcinom... Cervical Carcin... Colon Carcinoma Colorectal Carc... Endometrial Car... Esophageal Carc... Gastric Carcino... Glioma Head and Neck C... Hematopoietic a... Kidney Carcinom... Liver Carcinoma Lung Carcinoma Lymphoma Malignant Uteri... Melanoma Multiple Myelom... Ovarian Carcino... Pancreatic Carc... Prostate Carcin... Rectal Carcinom... Recurrent Bladd... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Color... Recurrent Esoph... Recurrent Gastr... Recurrent Gliom... Recurrent Head ... Recurrent Liver... Recurrent Lung ... Recurrent Lymph... Recurrent Malig... Recurrent Melan... Recurrent Multi... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Skin ... Recurrent Thyro... Recurrent Uteri... Refractory Lymp... Refractory Mali... Refractory Mult... Skin Carcinoma Thyroid Gland C... Uterine Corpus ...	Adavosertib Afatinib Afatinib Dimale... Binimetinib Biopsy Biospecimen Col... Capivasertib Computed Tomogr... Copanlisib Copanlisib Hydr... Crizotinib Cytology Specim... Dabrafenib Dabrafenib Mesy... Dasatinib Defactinib Defactinib Hydr... Echocardiograph... Erdafitinib Fexagratinib Ipatasertib Laboratory Biom... Larotrectinib Larotrectinib S... Magnetic Resona... Multigated Acqu... Nivolumab Osimertinib Palbociclib Pertuzumab PI3K-beta Inhib... Radiologic Exam... Radionuclide Im... Relatlimab Sapanisertib Sunitinib Malat... Taselisib Trametinib Trastuzumab Trastuzumab Emt... Ulixertinib Vismodegib	18 Years -	National Cancer Institute (NCI)
hARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study"	NCT03824691	Bladder Carcino...	Cabozantinib Durvalumab	18 Years - 90 Years	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics	NCT05819827	Bladder Cancer Prostate Cancer Testicular Canc... Bladder Carcino... Genitourinary S... Malignant Testi... Melanoma Prostate Carcin... Sarcoma	Blood and Tissu...	20 Years -	Mayo Clinic
PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare Providers	NCT02408406	Bladder Carcino... Breast Carcinom... Colorectal Carc... Lung Carcinoma Malignant Femal... Malignant Neopl...	Communication I... Educational Int... Internet-Based ... Quality-of-Life... Questionnaire A...	21 Years -	City of Hope Medical Center
Bladder Bank (a Prospective Banking Study)	NCT06109857	Bladder Carcino... Hematuria	Non-Interventio...	18 Years -	Mayo Clinic
Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery	NCT03757949	Bladder Carcino...	Laboratory Biom... Nutritional Int... Placebo Adminis... Quality-of-Life... Questionnaire A...	18 Years -	SWOG Cancer Research Network
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation	NCT05059444	Bladder Carcino... Ureter Carcinom... Renal Pelvis Ca... Non-small Cell ... Invasive Breast... Cutaneous Melan... Esophageal Carc... Gastroesophagea... Gastric Adenoca... Pancreatic Aden... Squamous Cell C... Epithelial Ovar... Fallopian Tube ... Endometrial Car... Renal Cell Carc...	Guardant Reveal	18 Years -	Guardant Health, Inc.
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)	NCT00753415	Non-Small Cell ... Breast Cancer Melanoma Upper GI Tract ... Colon Carcinoma Renal Cell Carc... Bladder Carcino... Prostate Cancer	V935 V934-EP	18 Years -	Merck Sharp & Dohme LLC
PUBMIC (Prophylactic Use of Biologic Mesh in Ileal Conduit)	NCT02439060	Bladder Carcino... Hernia	Acellular Cadav...	-	University of Southern California
PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare Providers	NCT02408406	Bladder Carcino... Breast Carcinom... Colorectal Carc... Lung Carcinoma Malignant Femal... Malignant Neopl...	Communication I... Educational Int... Internet-Based ... Quality-of-Life... Questionnaire A...	21 Years -	City of Hope Medical Center
EffectiveNess of a Multimodal preHAbilitation Program in patieNts With Bladder canCEr Undergoing Cystectomy	NCT05480735	Bladder Carcino...	Prehabilitation	18 Years -	The Netherlands Cancer Institute
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers	NCT05519878	Bladder Carcino... Genitourinary S... Kidney Carcinom... Prostate Carcin...	Best Practice Bright White Li... Occupational Th... Questionnaire A...	18 Years -	City of Hope Medical Center
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation	NCT05059444	Bladder Carcino... Ureter Carcinom... Renal Pelvis Ca... Non-small Cell ... Invasive Breast... Cutaneous Melan... Esophageal Carc... Gastroesophagea... Gastric Adenoca... Pancreatic Aden... Squamous Cell C... Epithelial Ovar... Fallopian Tube ... Endometrial Car... Renal Cell Carc...	Guardant Reveal	18 Years -	Guardant Health, Inc.

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: